冠心病合并房颤的抗栓策略

mbo-embolismР2РVascular diseaseaР1РAge 65–74Р1РSex category (i.e. female sex)Р1РMaximum scoreР9Р根据评分选择抗凝策略РRisk categoryРCHA2DS2-VASc?scoreРmended?antithrombotic therapyРOne ‘major’ risk?factor or ≥2 ‘clinically?relevant non-major’?risk factorsР≥2(male)?≥3(female)РOAC (I,A)РOne ‘clinically relevant?non-major’ risk factorР1(male)? 2(female)РOAC (IIa,B)РNo risk factorsР0РNo OAC ?No APDР2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016 Aug 27.РHAS-BLED评分РLetterРClinical characteristicaРPoints awardedРHРHypertensionР1РAРAbnormal renal and liver?function (1 point each)Р1or 2РSРStrokeР1РBРBleedingР1РLРLabile INRsР1РEРElderly (e.g. age >65 yearsР1РDРDrugs or alcohol (1 point each)Р1or 2РMaximum 9 pointsР0-2分为出血低风险患者,≥3 分时提示患者出血风险高。